Area of research
Immunology · Reproductive Medicine
Research interest
Research interests include Materials science, Composite material, Bevacizumab, Medicine, Chemotherapy, and Cervical cancer.
The role and prognostic value of PANoptosis-related genes in skin cutaneous melanoma
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
Recombinant humanized type I collagen remodels decidual immune microenvironment at maternal-fetal interface by modulating Th17/Treg imbalance
Impact of interfacial texture on failure behaviour of 8YSZ thermal barrier coatings under thermal cyclic loading
Bacterial Lipopeptides Are Effective against Pear Fire Blight
Recombinant humanized collagen remodels endometrial immune microenvironment of chronic endometritis through macrophage immunomodulation
Recombinant humanized collagen type III with high antitumor activity inhibits breast cancer cells autophagy, proliferation, and migration through DDR1
Injectable recombinant human collagen-derived material with high cell adhesion activity limits adverse remodelling and improves pelvic floor function in pelvic floor dysfunction rats
Curved coating structures improve the durability of corrosion-resistant coatings on the heated surfaces of coal-fired boilers
Constitutive Activation of Nuclear Factor κB Contributes to Cystic Fibrosis Transmembrane Conductance Regulator Expression and Promotes Human Cervical Cancer Progression and Poor Prognosis
Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis